IVF Services Market by Cycle Type (Fresh IVF Cycles (Non-Donor), Thawed IVF Cycles (Non-Donor), and Donor Egg IVF Cycles), and End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes) - Global Opportunity Analysis and I

IVF Services Market by Cycle Type (Fresh IVF Cycles (Non-Donor), Thawed IVF Cycles (Non-Donor), and Donor Egg IVF Cycles), and End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes) - Global Opportunity Analysis and Industry Forecast, 2018-2025

In vitro fertilization is an assisted reproductive technology (ART), which involves retrieving eggs from a woman’s ovaries and fertilizing them with sperm outside the body, in vitro. The global IVF services revenue market generated $10,587 million in 2017 and is projected to reach $22,467 million by 2025, growing at a CAGR of 9.8% from 2018 to 2025.

The global IVF services market is anticipated to exhibit significant market growth during the forecast period, owing to rise in infertility rate, increase in trend of delayed pregnancies, surge in IVF success rate, and rise in disposable income worldwide. However, high cost, complications associated with IVF treatment, and low awareness level for IVF in some under developed regions hinder the growth of the market. Conversely, upsurge in fertility tourism, increase in number of fertility clinics, and growth opportunities in the emerging markets make way for market development in the future.
The global IVF services market is segmented based on cycle type, end user, and region. Based on cycle type, the market is divided into fresh IVF cycle (non-donor), thawed IVF cycle (non-donor), and donor egg IVF cycle. According to end user, the market is classified as fertility clinics, hospitals, surgical centers and clinical research institutes. Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia, Denmark, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, Thailand, New Zealand, South Korea and rest of Asia-Pacific), and LAMEA (Latin America, Middle East, and Africa).

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.

Key players are profiled to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Cycle Type

Fresh IVF Cycles (Non-Donor)
Thawed IVF Cycles (Non-Donor)
Donor Egg IVF Cycles

By End User

Fertility Clinics
Hospitals
Surgical centers
Clinical research institutes

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Denmark
Russia
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
New Zealand
Thailand
Rest of Asia-Pacific
LAMEA
Latin America
Middle East
Africa

LIST OF KEY PLAYERS PROFILED IN THE REPORT

Ambroise Paré Group
amedes MVZ Cologne GmbH

AMP Center St Roch

AVA Clinic Scanfert

Bangkok IVF center
Bangkok IVF center (Bangkok Hospital)
Betamedics
Biofertility Center
Bloom Fertility and Healthcare
Bloom Fertility Center
Bourn Hall Fertility Center
Bourn Hall International
Cardone Reproductive Medicine and Infertility, LLC
Center for Advanced Reproductive Medicine and Infertility

CHA Fertility Center

Chelsea and Westminster Hospital (Assisted Conception Unit)
Cloudnine Fertility
Conceptions Reproductive Associates of Colorado
Cyprus IVF Centre
Dansk Fertilitetsklinik

EUVITRO S.L.U.

Fakih IVF Fertility Center
Fertility and Gynecology Center Monterey Bay IVF
Fertility Associates
Fertility Center Berlin
Fertility Center of San Antoni
Fertility First

FIV Marbella

Fivet Centers Prof. Zech
Flinders Reproductive Medicine Pty Ltd
Genea Oxford Fertility Limited
Heidelberg University Hospital
Houston Fertility Center
International Centre for Reproductive Medicine, ICRM

IVF Canada

IVF NAMBA Clinic

IVF Panama Center for Reproduction Punta Pacífica

IVF Spain

IVI Panama

Ivinsemer
KL Fertility & Gynaecology Centre
Lifesure Fertility and Gynaecology centre

LIV Fertility Center

Manipal Fertility
Maria Fertility Hospital
MD Medical Group
Medfem Fertility Clinic
Monash IVF Wesley Hospital Auchenflower
Morpheus Life Sciences Pvt. Ltd.
New hope fertility center
Oak Medical Group/Oak Clinic

OVA IVF Clinic Zurich

Procrea Fertility

RAPRUI Srl

Repromed

SAFE Fertility Center

Sanno Hospital
Servy Massey Fertility Institute
Shanghai Ji Ai Genetics & IVF Institute
Shanghai United Family Hospital
Sher Institute for Reproductive Medicine (SIRM)
Southend Fertility and IVF
StorkKlinik (Stork IVF Clinic)
The ARC-STER Center
The Bridge Centre
The Cape Fertility Clinic
The Hugh Wynter Fertility Management Unit
The Lister Fertility Clinic
The Montreal Fertility Center
Thomson Medical Pte. Ltd.
Trianglen Fertility Clinic

TRIO Fertility

Virtus Health
Vitanova
VivaNeo - Medical Center Kinderwens
Wunschkinder


CHAPTER 1. INTRODUCTION
1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key Findings of the Study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. IVF Pricing Trends
3.3. IVF Cycles, By Country
3.4. Global IVF Services Market, By End User
3.4.1. Market size and forecast
3.4.2. Market volume and forecast
3.4.3. Fertility clinics
3.4.3.1. Market size and forecast
3.4.4. Hospitals
3.4.4.1. Market size and forecast
3.4.5. Surgical centers
3.4.5.1. Market size and forecast
3.4.6. Clinical research institutes
3.4.6.1. Market size and forecast
3.5. Global IVF Services Market, By Cycle Type
3.5.1. Market size and forecast
3.5.2. Market volume and forecast
3.5.3. Fresh IVF cycles (non-donor)
3.5.3.1. Market size and forecast
3.5.4. Thawed IVF cycles (non-donor)
3.5.4.1. Market size and forecast
3.5.5. Donor egg IVF cycles
3.5.5.1. Market size and forecast
3.6. Market Dynamics
3.6.1. Drivers
3.6.1.1. Delayed pregnancies in women
3.6.1.2. Increase in global infertility rates
3.6.1.3. Increase in gamete donations
3.6.1.4. Increase in disposable income
3.6.1.5. Increase in IVF success rates
3.6.1.6. Surge in healthcare expenditure worldwide
3.6.2. Restraints
3.6.2.1. Cost constraints
3.6.2.2. Complications associated with IVF treatment
3.6.2.3. Low awareness level
3.6.3. Opportunities
3.6.3.1. Fertility tourism
3.6.3.2. Growth opportunities in the emerging markets
3.6.3.3. Increase in number of fertility clinics
3.6.3.4. Rise in same sex marriage
3.6.4. Impact analyses
3.7. Key Findings
CHAPTER 4: NORTH AMERICA IVF SERVICES MARKET
4.1. Overview
4.1.1. Market size and forecast
4.1.1.1. By country
4.1.1.2. By end user
4.1.1.3. By cycle type
4.1.2. Market volume and forecast
4.1.2.1. By country
4.1.2.2. By end user
4.1.2.3. By cycle type
4.2. U.S. IVF Services Market, (Revenue and Number of Cycles)
4.2.1. Overview
4.2.2. Market size and forecast
4.2.3. IVF clinics in the U.S.
4.2.4. U.S. IVF services market, by end user
4.2.4.1. Market size and forecast
4.2.4.2. Market volume and forecast
4.2.4.3. Fertility clinics
4.2.4.4. Hospitals
4.2.4.5. Surgical centers
4.2.4.6. Clinical research institutes
4.2.5. U.S. IVF services market, by cycle type
4.2.5.1. Market size and forecast
4.2.5.2. Market volume and forecast
4.2.5.3. Fresh IVF cycles (non-donor)
4.2.5.4. Thawed IVF cycles (non-donor)
4.2.5.5. Donor egg IVF cycles
4.2.6. Market dynamics
4.2.6.1. Driving factors
4.2.6.1.1. Increasing popularity of IVF in U.S.
4.2.6.1.2. Increased rate of infertility and practices of embryo banking cycles
4.2.6.2. Restraining factors
4.2.6.2.1. High cost of IVF treatment in U.S.
4.2.6.2.2. Restrictions on 3-parent IVF treatments
4.2.6.2.3. Scattered Reimbursements
4.2.7. Regulatory issues, legislations and authorities
4.2.8. Insurance reimbursement scenario
4.2.9. Company profiles
4.2.9.1. Fertility and Gynecology Center Monterey Bay IVF
4.2.9.1.1. Company overview
4.2.9.2. Conceptions Reproductive Associates of Colorado
4.2.9.2.1. Company overview
4.2.9.3. Servy Massey Fertility Institute
4.2.9.3.1. Company overview
4.2.9.4. Sher Institute for Reproductive Medicine (SIRM)
4.2.9.4.1. Company overview
4.2.9.5. Cardone Reproductive Medicine and Infertility, LLC
4.2.9.5.1. Company overview
4.2.9.6. Fertility Center of San Antoni
4.2.9.6.1. Company overview
4.2.9.7. Houston Fertility Center
4.2.9.7.1. Company overview
4.2.9.8. New hope fertility center
4.2.9.8.1. Company overview
4.3. Canada IVF Services Market, (Revenue and Number of Cycles)
4.3.1. Overview
4.3.2. Market size and forecast
4.3.3. IVF clinics in Canada
4.3.4. Canada IVF services market, by end user
4.3.4.1. Market size and forecast
4.3.4.2. Market volume and forecast
4.3.4.3. Fertility clinics
4.3.4.4. Hospitals
4.3.4.5. Surgical centers
4.3.4.6. Clinical research institutes
4.3.5. Canada IVF services market, by cycle type
4.3.5.1. Market size and forecast
4.3.5.2. Market volume and forecast
4.3.5.3. Fresh IVF cycles (non-donor)
4.3.5.4. Thawed IVF cycles (non-donor)
4.3.5.5. Donor egg IVF cycles
4.3.6. Market dynamics
4.3.6.1. Driving factors
4.3.6.1.1. Commercialization of IVF booster in Canada
4.3.6.2. Restraining factors
4.3.6.2.1. High cost of IVF treatment in Canada
4.3.7. Regulatory issues, legislations and authorities
4.3.8. Insurance reimbursement scenario
4.3.9. Company profiles
4.3.9.1. TRIO Fertility
4.3.9.1.1. Company overview
4.3.9.2. The Montreal Fertility Center
4.3.9.2.1. Company overview
4.3.9.3. Procrea Fertility
4.3.9.3.1. Company overview
4.3.9.4. IVF Canada
4.3.9.4.1. Company overview
4.4. Mexico IVF Services Market, (Revenue and Number of Cycles)
4.4.1. Overview
4.4.2. Market size and forecast
4.4.3. IVF clinics in Mexico
4.4.4. Mexico IVF services market, by end user
4.4.4.1. Market size and forecast
4.4.4.2. Market volume and forecast
4.4.4.3. Fertility clinics
4.4.4.4. Hospitals
4.4.4.5. Surgical centers
4.4.4.6. Clinical research institutes
4.4.5. Mexico IVF services market, by cycle type
4.4.5.1. Market size and forecast
4.4.5.2. Market volume and forecast
4.4.5.3. Fresh IVF cycles (non-donor)
4.4.5.4. Thawed IVF cycles (non-donor)
4.4.5.5. Donor egg IVF cycles
4.4.6. Market dynamics
4.4.6.1. Driving factors
4.4.6.1.1. Fertility tourism
4.4.6.1.2. Comparatively low cost of IVF
4.4.6.2. Restraining factors
4.4.6.2.1. Language barriers
4.4.7. Regulatory issues, legislations and authorities
4.4.8. Insurance reimbursement scenario
4.4.9. Company profiles
4.4.9.1. LIV Fertility Center
4.4.9.1.1. Company overview
4.4.9.2. Biofertility Center
4.4.9.2.1. Company overview
4.4.9.3. Ivinsemer
4.4.9.3.1. Company overview
CHAPTER 5: EUROPE IVF SERVICES MARKET
5.1. Overview
5.1.1. Market size and forecast
5.1.1.1. By country
5.1.1.2. By end user
5.1.1.3. By cycle type
5.1.2. Market volume and forecast
5.1.2.1. By country
5.1.2.2. By end user
5.1.2.3. By cycle type
5.2. Germany IVF Services Market, (Revenue and Number of Cycles)
5.2.1. Overview
5.2.2. Market size and forecast
5.2.3. IVF clinics in Germany
5.2.4. Germany IVF services market, by end user
5.2.4.1. Market size and forecast
5.2.4.2. Market volume and forecast
5.2.4.3. Fertility clinics
5.2.4.4. Hospitals
5.2.4.5. Surgical centers
5.2.4.6. Clinical research institutes
5.2.5. Germany IVF services market, by cycle type
5.2.5.1. Market size and forecast
5.2.5.2. Market volume and forecast
5.2.5.3. Fresh IVF cycles (non-donor)
5.2.5.4. Thawed IVF cycles (non-donor)
5.2.6. Market dynamics
5.2.6.1. Driving factors
5.2.6.1.1. Subsidizing IVF treatments
5.2.6.1.2. Delayed marriages and parenthood decisions
5.2.6.2. Restraining factors
5.2.6.2.1. Limited adoption of IVF methods
5.2.7. Regulatory issues, legislations and authorities
5.2.8. Insurance reimbursement scenario
5.2.9. Company profiles
5.2.9.1. Heidelberg University Hospital
5.2.9.1.1. Company overview
5.2.9.2. Wunschkinder
5.2.9.2.1. Company overview
5.2.9.3. Fertility Center Berlin
5.2.9.3.1. Company overview
5.2.9.4. amedes MVZ Cologne GmbH
5.2.9.4.1. Company overview
5.3. France IVF Services Market, (Revenue and Number of Cycles)
5.3.1. Overview
5.3.2. Market size and forecast
5.3.3. IVF clinics in France
5.3.4. France IVF services market, by end user
5.3.4.1. Market size and forecast
5.3.4.2. Market volume and forecast
5.3.4.3. Fertility clinics
5.3.4.4. Hospitals
5.3.4.5. Surgical centers
5.3.4.6. Clinical research institutes
5.3.5. France IVF services market, by cycle type
5.3.5.1. Market size and forecast
5.3.5.2. Market volume and forecast
5.3.5.3. Fresh IVF cycles (non-donor)
5.3.5.4. Thawed IVF cycles (non-donor)
5.3.5.5. Donor egg IVF cycles
5.3.6. Market dynamics
5.3.6.1. Driving factors
5.3.6.1.1. Rising adoption of IVF babies among same gender population
5.3.6.1.2. Lower rates of Fertility
5.3.6.2. Restraining factors
5.3.6.2.1. Stringent government regulations
5.3.7. Regulatory issues, legislations and authorities
5.3.8. Insurance reimbursement scenario
5.3.9. Company profiles
5.3.9.1. Ambroise Par Group
5.3.9.1.1. Company overview
5.3.9.2. AMP Center St Roch
5.3.9.2.1. Company overview
5.4. UK IVF Services Market, (Revenue and Number of Cycles)
5.4.1. Overview
5.4.2. Market size and forecast
5.4.3. IVF clinics in UK
5.4.4. UK IVF services market, by end user
5.4.4.1. Market size and forecast
5.4.4.2. Market volume and forecast
5.4.4.3. Fertility clinics
5.4.4.4. Hospitals
5.4.4.5. Surgical centers
5.4.4.6. Clinical research institutes
5.4.5. UK IVF services market, by cycle type
5.4.5.1. Market size and forecast
5.4.5.2. Market volume and forecast
5.4.5.3. Fresh IVF cycles (non-donor)
5.4.5.4. Thawed IVF cycles (non-donor)
5.4.5.5. Donor egg IVF cycles
5.4.6. Market dynamics
5.4.6.1. Driving factors
5.4.6.1.1. Commercialization of three-parent IVF procedures
5.4.6.1.2. Supportive Regulations
5.4.6.2. Restraining factors
5.4.6.2.1. Ethical considerations
5.4.7. Regulatory issues, legislations and authorities
5.4.8. Insurance reimbursement scenario
5.4.9. Company profiles
5.4.9.1. The Lister Fertility Clinic
5.4.9.1.1. Company overview
5.4.9.2. The Bridge Centre
5.4.9.2.1. Company overview
5.4.9.3. Chelsea and Westminster Hospital (Assisted Conception Unit)
5.4.9.3.1. Company overview
5.5. Italy IVF Services Market, (Revenue and Number of Cycles)
5.5.1. Overview
5.5.2. Market size and forecast
5.5.3. Italy IVF services market, by end user
5.5.3.1. Market size and forecast
5.5.3.2. Market volume and forecast
5.5.3.3. Fertility clinics
5.5.3.4. Hospitals
5.5.3.5. Surgical centers
5.5.3.6. Clinical research institutes
5.5.4. Italy IVF services market, by cycle type
5.5.4.1. Market size and forecast
5.5.4.2. Market volume and forecast
5.5.4.3. Fresh IVF cycles (non-donor)
5.5.4.4. Thawed IVF cycles (non-donor)
5.5.4.5. Donor egg IVF cycles
5.5.5. Market dynamics
5.5.5.1. Driving factors
5.5.5.1.1. Rise in medical tourism
5.5.5.2. Restraining factors
5.5.5.2.1. Ban on surrogacy
5.5.6. Regulatory issues, legislations and authorities
5.5.7. Insurance reimbursement scenario
5.5.8. Company profiles
5.5.8.1. The ARC-STER Center
5.5.8.1.1. Company overview
5.5.8.2. RAPRUI Srl
5.5.8.2.1. Company overview
5.5.8.3. Fivet Centers Prof. Zech
5.5.8.3.1. Company overview
5.6. Spain IVF Services Market, (Revenue and Number of Cycles)
5.6.1. Overview
5.6.2. Market size and forecast
5.6.3. Spain IVF services market, by end user
5.6.3.1. Market size and forecast
5.6.3.2. Market volume and forecast
5.6.3.3. Fertility clinics
5.6.3.4. Hospitals
5.6.3.5. Surgical centers
5.6.3.6. Clinical research institutes
5.6.4. Spain IVF services market, by cycle type
5.6.4.1. Market size and forecast
5.6.4.2. Market volume and forecast
5.6.4.3. Fresh IVF cycles (non-donor)
5.6.4.4. Thawed IVF cycles (non-donor)
5.6.4.5. Donor egg IVF cycles
5.6.5. Market dynamics
5.6.5.1. Driving factors
5.6.5.1.1. Increase in the number of foreign patients
5.6.5.2. Restraining factors
5.6.5.2.1. Limited awareness and language barriers
5.6.6. Regulatory issues, legislations and authorities
5.6.7. Insurance reimbursement scenario
5.6.8. Company profiles
5.6.8.1. IVF Spain
5.6.8.1.1. Company overview
5.6.8.2. EUVITRO S.L.U.
5.6.8.2.1. Company overview
5.6.8.3. FIV Marbella
5.6.8.3.1. Company overview
5.7. Denmark IVF Services Market, (Revenue and Number of Cycles)
5.7.1. Overview
5.7.2. Market size and forecast
5.7.3. Denmark IVF services market, by end user
5.7.3.1. Market size and forecast
5.7.3.2. Market volume and forecast
5.7.3.3. Fertility clinics
5.7.3.4. Hospitals
5.7.3.5. Surgical centers
5.7.3.6. Clinical research institutes
5.7.4. Denmark IVF services market, by cycle type
5.7.4.1. Market size and forecast
5.7.4.2. Market volume and forecast
5.7.4.3. Fresh IVF cycles (non-donor)
5.7.4.4. Thawed IVF cycles (non-donor)
5.7.4.5. Donor egg IVF cycles
5.7.5. Market dynamics
5.7.5.1. Driving factors
5.7.5.1.1. Increase in disposable income
5.7.5.1.2. Advances in IVF technology
5.7.5.2. Restraining factors
5.7.5.2.1. Reimbursement in public clinics only
5.7.6. Regulatory issues, legislations and authorities
5.7.7. Insurance reimbursement scenario
5.7.8. Company profiles
5.7.8.1. Vitanova
5.7.8.1.1. Company overview
5.7.8.2. Dansk Fertilitetsklinik
5.7.8.2.1. Company overview
5.7.8.3. StorkKlinik (Stork IVF Clinic)
5.7.8.3.1. Company overview
5.7.8.4. Trianglen Fertility Clinic
5.7.8.4.1. Company overview
5.8. Russia IVF Services Market, (Revenue and Number of Cycles)
5.8.1. Overview
5.8.2. Market size and forecast
5.8.3. Russia IVF services market, by end user
5.8.3.1. Market size and forecast
5.8.3.2. Market volume and forecast
5.8.3.3. Fertility clinics
5.8.3.4. Hospitals
5.8.3.5. Surgical centers
5.8.3.6. Clinical research institutes
5.8.4. Russia IVF services market, by cycle type
5.8.4.1. Market size and forecast
5.8.4.2. Market volume and forecast
5.8.4.3. Fresh IVF cycles (non-donor)
5.8.4.4. Thawed IVF cycles (non-donor)
5.8.4.5. Donor egg IVF cycles
5.8.5. Market dynamics
5.8.5.1. Driving factors
5.8.5.1.1. Rising popularity of fertility tourism
5.8.5.2. Restraining factors
5.8.5.2.1. Language barrier
5.8.6. Regulatory issues, legislations and authorities
5.8.7. Insurance reimbursement scenario
5.8.8. Company profiles
5.8.8.1. AVA Clinic Scanfert
5.8.8.1.1. Company overview
5.8.8.2. MD Medical Group
5.8.8.2.1. Company overview
5.8.8.3. International Centre for Reproductive Medicine, ICRM
5.8.8.3.1. Company overview
5.9. Rest of Europe IVF Services Market, (Revenue and Number of Cycles)
5.9.1. Overview
5.9.2. Market size and forecast
5.9.3. Rest of Europe IVF services market, by end user
5.9.3.1. Market size and forecast
5.9.3.2. Market volume and forecast
5.9.3.3. Fertility clinics
5.9.3.4. Hospitals
5.9.3.5. Surgical centers
5.9.3.6. Clinical research institutes
5.9.4. Rest of Europe IVF services market, by cycle type
5.9.4.1. Market size and forecast
5.9.4.2. Market volume and forecast
5.9.4.3. Fresh IVF cycles (non-donor)
5.9.4.4. Thawed IVF cycles (non-donor)
5.9.4.5. Donor egg IVF cycles
5.9.5. Market dynamics
5.9.5.1. Driving factors
5.9.5.1.1. Wide availability of reimbursements
5.9.5.1.2. Changes in lifestyle
5.9.5.2. Restraining factors
5.9.6. Regulatory issues, legislations and authorities
5.9.7. Insurance reimbursement scenario
5.9.8. Company profiles
5.9.8.1. Betamedics
5.9.8.1.1. Company overview
5.9.8.2. OVA IVF Clinic Zurich
5.9.8.2.1. Company overview
5.9.8.3. VivaNeo - Medical Center Kinderwens
5.9.8.3.1. Company overview
CHAPTER 6: ASIA-PACIFIC IVF SERVICES MARKET
6.1. Overview
6.1.1. Market size and forecast
6.1.1.1. By country
6.1.1.2. By end user
6.1.1.3. By cycle type
6.1.2. Market volume and forecast
6.1.2.1. By country
6.1.2.2. By end user
6.1.2.3. By cycle type
6.2. India IVF Services Market, (Revenue and Number of Cycles)
6.2.1. Overview
6.2.2. Market size and forecast
6.2.3. IVF clinics in India
6.2.4. India IVF services market, by end user
6.2.4.1. Market size and forecast
6.2.4.2. Market volume and forecast
6.2.4.3. Fertility clinics
6.2.4.4. Hospitals
6.2.4.5. Surgical centers
6.2.4.6. Clinical research institutes
6.2.5. India IVF services market, by cycle type
6.2.5.1. Market size and forecast
6.2.5.2. Market volume and forecast
6.2.5.3. Fresh IVF cycles (non-donor)
6.2.5.4. Thawed IVF cycles (non-donor)
6.2.5.5. Donor egg IVF cycles
6.2.6. Market dynamics
6.2.6.1. Driving factors
6.2.6.2. Restraining factors
6.2.7. Regulatory issues, legislations and authorities
6.2.8. Insurance reimbursement scenario
6.2.9. Company profiles
6.2.9.1. Bourn Hall Fertility Center
6.2.9.1.1. Company overview
6.2.9.2. Southend Fertility and IVF
6.2.9.2.1. Company overview
6.2.9.3. Morpheus Life Sciences Pvt. Ltd.
6.2.9.3.1. Company overview
6.2.9.4. Bloom Fertility Center
6.2.9.4.1. Company overview
6.2.9.5. Bloom Fertility and Healthcare
6.2.9.5.1. Company overview
6.2.9.6. Manipal Fertility
6.2.9.6.1. Company overview
6.2.9.7. Cloudnine Fertility
6.2.9.7.1. Company overview
6.3. China IVF Services Market, (Revenue and Number of Cycles)
6.3.1. Overview
6.3.2. Market size and forecast
6.3.3. China IVF services market, by end user
6.3.3.1. Market size and forecast
6.3.3.2. Market volume and forecast
6.3.3.3. Fertility clinics
6.3.3.4. Hospitals
6.3.3.5. Surgical centers
6.3.3.6. Clinical research institutes
6.3.4. China IVF services market, by cycle type
6.3.4.1. Market size and forecast
6.3.4.2. Market volume and forecast
6.3.4.3. Fresh IVF cycles (non-donor)
6.3.4.4. Thawed IVF cycles (non-donor)
6.3.4.5. Donor egg IVF cycles
6.3.5. Market dynamics
6.3.5.1. Driving factors
6.3.5.2. Restraining factors
6.3.6. Regulatory issues, legislations and authorities
6.3.7. Insurance reimbursement scenario
6.3.8. Company profiles
6.3.8.1. Shanghai Ji Ai Genetics & IVF Institute
6.3.8.1.1. Company overview
6.3.8.2. Shanghai United Family Hospital
6.3.8.2.1. Company overview
6.4. Japan IVF Services Market, (Revenue and Number of Cycles)
6.4.1. Overview
6.4.2. Market size and forecast
6.4.3. Japan IVF services market, by end user
6.4.3.1. Market size and forecast
6.4.3.2. Market volume and forecast
6.4.3.3. Fertility clinics
6.4.3.4. Hospitals
6.4.3.5. Surgical centers
6.4.3.6. Clinical research institutes
6.4.4. Japan IVF services market, by cycle type
6.4.4.1. Market size and forecast
6.4.4.2. Market volume and forecast
6.4.4.3. Fresh IVF cycles (non-donor)
6.4.4.4. Thawed IVF cycles (non-donor)
6.4.4.5. Donor egg IVF cycles
6.4.5. Market dynamics
6.4.5.1. Driving factors
6.4.5.2. Restraining factors
6.4.6. Regulatory issues, legislations and authorities
6.4.7. Insurance reimbursement scenario
6.4.8. Company profiles
6.4.8.1. IVF NAMBA Clinic
6.4.8.1.1. Company overview
6.4.8.2. Sanno Hospital
6.4.8.2.1. Company overview
6.4.8.3. Oak Medical Group/Oak Clinic
6.4.8.3.1. Company overview
6.5. Australia IVF Services Market, (Revenue and Number of Cycles)
6.5.1. Overview
6.5.2. Market size and forecast
6.5.3. IVF clinics in Australia
6.5.4. Australia IVF services market, by end user
6.5.4.1. Market size and forecast
6.5.4.2. Market volume and forecast
6.5.4.3. Fertility clinics
6.5.4.4. Hospitals
6.5.4.5. Surgical centers
6.5.4.6. Clinical research institutes
6.5.5. Australia IVF services market, by cycle type
6.5.5.1. Market size and forecast
6.5.5.2. Market volume and forecast
6.5.5.3. Fresh IVF cycles (non-donor)
6.5.5.4. Thawed IVF cycles (non-donor)
6.5.5.5. Donor egg IVF cycles
6.5.6. Market dynamics
6.5.6.1. Driving factors
6.5.6.2. Restraining factors
6.5.7. Regulatory issues, legislations and authorities
6.5.8. Insurance reimbursement scenario
6.5.9. Company profiles
6.5.9.1. Virtus Health
6.5.9.1.1. Company overview
6.5.9.2. Monash IVF Wesley Hospital Auchenflower
6.5.9.2.1. Company overview
6.5.9.3. Fertility First
6.5.9.3.1. Company overview
6.5.9.4. Flinders Reproductive Medicine Pty Ltd
6.5.9.4.1. Company overview
6.6. New Zealand IVF Services Market, (Revenue and Number of Cycles)
6.6.1. Overview
6.6.2. Market size and forecast
6.6.3. New Zealand IVF services market, by end user
6.6.3.1. Market size and forecast
6.6.3.2. Market volume and forecast
6.6.3.3. Fertility clinics
6.6.3.4. Hospitals
6.6.3.5. Surgical centers
6.6.3.6. Clinical research institutes
6.6.4. New Zealand IVF services market, by cycle type
6.6.4.1. Market size and forecast
6.6.4.2. Market volume and forecast
6.6.4.3. Fresh IVF cycles (non-donor)
6.6.4.4. Thawed IVF cycles (non-donor)
6.6.4.5. Donor egg IVF cycles
6.6.5. Market dynamics
6.6.5.1. Driving factors
6.6.5.2. Restraining factors
6.6.6. Regulatory issues, legislations and authorities
6.6.7. Insurance reimbursement scenario
6.6.8. Company profiles
6.6.8.1. Fertility Associates
6.6.8.1.1. Company overview
6.6.8.2. Genea Oxford Fertility Limited
6.6.8.2.1. Company overview
6.6.8.3. Repromed
6.6.8.3.1. Company overview
6.7. South Korea IVF Services Market, (Revenue and Number of Cycles)
6.7.1. Overview
6.7.2. Market size and forecast
6.7.3. IVF clinics in South Korea
6.7.4. South Korea IVF Services Market, by end user
6.7.4.1. Market size and forecast
6.7.4.2. Market volume and forecast
6.7.4.3. Fertility clinics
6.7.4.4. Hospitals
6.7.4.5. Surgical centers
6.7.4.6. Clinical research institutes
6.7.5. South Korea IVF services market, by cycle type
6.7.5.1. Market size and forecast
6.7.5.2. Market volume and forecast
6.7.5.3. Fresh IVF cycles (non-donor)
6.7.5.4. Thawed IVF cycles (non-donor)
6.7.5.5. Donor egg IVF cycles
6.7.6. Market dynamics
6.7.6.1. Driving factors
6.7.6.2. Restraining factors
6.7.7. Regulatory issues, legislations and authorities
6.7.8. Insurance reimbursement scenario
6.7.9. Company profiles
6.7.9.1. CHA Fertility Center
6.7.9.1.1. Company overview
6.7.9.2. Maria Fertility Hospital
6.7.9.2.1. Company overview
6.8. Thailand IVF Services Market, (Revenue and Number of Cycles)
6.8.1. Overview
6.8.2. Market size and forecast
6.8.3. Thailand IVF services market, by end user
6.8.3.1. Market size and forecast
6.8.3.2. Market volume and forecast
6.8.3.3. Fertility clinics
6.8.3.4. Hospitals
6.8.3.5. Surgical centers
6.8.3.6. Clinical research institutes
6.8.4. Thailand IVF services market, by cycle type
6.8.4.1. Market size and forecast
6.8.4.2. Market volume and forecast
6.8.4.3. Fresh IVF cycles (non-donor)
6.8.4.4. Thawed IVF cycles (non-donor)
6.8.4.5. Donor egg IVF cycles
6.8.5. Market dynamics
6.8.5.1. Driving factors
6.8.5.2. Restraining factors
6.8.6. Regulatory issues, legislations and authorities
6.8.7. Insurance reimbursement scenario
6.8.8. Company profiles
6.8.8.1. SAFE Fertility Center
6.8.8.1.1. Company overview
6.8.8.2. Bangkok IVF center (Bangkok Hospital)
6.8.8.2.1. Company overview
6.8.8.3. Bangkok IVF center
6.8.8.3.1. Company overview
6.9. Rest of Asia-Pacific IVF Services Market, (Revenue and Number of Cycles)
6.9.1. Overview
6.9.2. Market size and forecast
6.9.3. Rest of Asia-Pacific IVF services market, by end user
6.9.3.1. Market size and forecast
6.9.3.2. Market volume and forecast
6.9.3.3. Fertility clinics
6.9.3.4. Hospitals
6.9.3.5. Surgical centers
6.9.3.6. Clinical research institutes
6.9.4. Rest of Asia-Pacific IVF services market, by cycle type
6.9.4.1. Market size and forecast
6.9.4.2. Market volume and forecast
6.9.4.3. Fresh IVF cycles (non-donor)
6.9.4.4. Thawed IVF cycles (non-donor)
6.9.4.5. Donor egg IVF cycles
6.9.5. Market dynamics
6.9.5.1. Driving factors
6.9.5.2. Restraining factors
6.9.6. Regulatory issues, legislations and authorities
6.9.7. Insurance reimbursement scenario
6.9.8. Company profiles
6.9.8.1. Center for Advanced Reproductive Medicine and Infertility
6.9.8.1.1. Company overview
6.9.8.2. Thomson Medical Pte. Ltd.
6.9.8.2.1. Company overview
6.9.8.3. KL Fertility & Gynaecology Centre
6.9.8.3.1. Company overview
CHAPTER 7: LAMEA IVF SERVICES MARKET
7.1. Overview
7.1.1. Market size and forecast
7.1.1.1. By country
7.1.1.2. By end user
7.1.1.3. By cycle type
7.1.2. Market volume and forecast
7.1.2.1. By country
7.1.2.2. By end user
7.1.2.3. By cycle type
7.2. Latin America IVF Services Market, (Revenue and Number of Cycles)
7.2.1. Overview
7.2.2. Market size and forecast
7.2.3. IVF clinics in Latin America
7.2.4. Latin America IVF services market, by end user
7.2.4.1. Market size and forecast
7.2.4.2. Market volume and forecast
7.2.4.3. Fertility clinics
7.2.4.4. Hospitals
7.2.4.5. Surgical centers
7.2.4.6. Clinical research institutes
7.2.5. Latin America IVF services market, by cycle type
7.2.5.1. Market size and forecast
7.2.5.2. Market volume and forecast
7.2.5.3. Fresh IVF cycles (non-donor)
7.2.5.4. Thawed IVF cycles (non-donor)
7.2.5.5. Donor egg IVF cycles
7.2.6. Market dynamics
7.2.6.1. Driving factors
7.2.6.2. Restraining factors
7.2.7. Regulatory issues, legislations and authorities
7.2.8. Insurance reimbursement scenario
7.2.9. Company profiles
7.2.9.1. IVI Panama
7.2.9.1.1. Company overview
7.2.9.2. IVF Panama Center for Reproduction Punta Pacfica
7.2.9.2.1. Company overview
7.2.9.3. The Hugh Wynter Fertility Management Unit
7.2.9.3.1. Company overview
7.3. Middle East IVF Services Market, (Revenue and Number of Cycles)
7.3.1. Overview
7.3.2. Market size and forecast
7.3.3. IVF clinics in Middle East
7.3.4. Middle East IVF services market, by end user
7.3.4.1. Market size and forecast
7.3.4.2. Market volume and forecast
7.3.4.3. Fertility clinics
7.3.4.4. Hospitals
7.3.4.5. Surgical centers
7.3.4.6. Clinical research institutes
7.3.5. Middle East IVF services market, by cycle type
7.3.5.1. Market size and forecast
7.3.5.2. Market volume and forecast
7.3.5.3. Fresh IVF cycles (non-donor)
7.3.5.4. Thawed IVF cycles (non-donor)
7.3.5.5. Donor egg IVF cycles
7.3.6. Market dynamics
7.3.6.1. Driving factors
7.3.6.2. Restraining factors
7.3.7. Regulatory issues, legislations and authorities
7.3.8. Insurance reimbursement scenario
7.3.9. Company profiles
7.3.9.1. Cyprus IVF Centre
7.3.9.1.1. Company overview
7.3.9.2. Bourn Hall International
7.3.9.2.1. Company overview
7.3.9.3. Fakih IVF Fertility Center
7.3.9.3.1. Company overview
7.4. Africa IVF Services Market, (Revenue and Number of Cycles)
7.4.1. Overview
7.4.2. Market size and forecast
7.4.3. IVF clinics in Africa
7.4.4. Africa IVF services market, by end user
7.4.4.1. Market size and forecast
7.4.4.2. Market volume and forecast
7.4.4.3. Fertility clinics
7.4.4.4. Hospitals
7.4.4.5. Surgical centers
7.4.4.6. Clinical research institutes
7.4.5. Africa IVF services market, by cycle type
7.4.5.1. Market size and forecast
7.4.5.2. Market volume and forecast
7.4.5.3. Fresh IVF cycles (non-donor)
7.4.5.4. Thawed IVF cycles (non-donor)
7.4.5.5. Donor egg IVF cycles
7.4.6. Market dynamics
7.4.6.1. Driving factors
7.4.6.2. Restraining factors
7.4.7. Regulatory issues, legislations and authorities
7.4.8. Insurance reimbursement scenario
7.4.9. Company profiles
7.4.9.1. Medfem Fertility Clinic
7.4.9.1.1. Company overview
7.4.9.2. The Cape Fertility Clinic
7.4.9.2.1. Company overview
7.4.9.3. Lifesure Fertility and Gynaecology Centre
7.4.9.3.1. Company overview
List of Tables
TABLE 01. IVF PRICING TRENDS, BY COUNTRY, 2017
TABLE 02. GLOBAL IVF MARKET, BY COUNTRY, 2016-2023 (THOUSAND)
TABLE 03. GLOBAL IVF SERVICES MARKET REVENUE, BY END USER, 2017-2025 ($MILLION)
TABLE 04. GLOBAL IVF SERVICES MARKET VOLUME, BY END USER, 2017-2025 (THOUSAND)
TABLE 05. GLOBAL IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2017-2025 ($MILLION)
TABLE 06. GLOBAL IVF SERVICES MARKET VOLUME, BY CYCLE TYPE, 2017-2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook